1 Patent Medicine Market Overview 1.1 Product Overview and Scope of Patent Medicine 1.2 Patent Medicine Segment by Type 1.2.1 Global Patent Medicine Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Product Patents 1.2.3 Process Patents 1.3 Patent Medicine Segment by Application 1.3.1 Patent Medicine Sales Comparison by Application: (2021-2027) 1.3.2 Adult 1.3.3 Children 1.4 Global Patent Medicine Market Size Estimates and Forecasts 1.4.1 Global Patent Medicine Revenue 2016-2027 1.4.2 Global Patent Medicine Sales 2016-2027 1.4.3 Patent Medicine Market Size by Region: 2016 Versus 2021 Versus 2027 2 Patent Medicine Market Competition by Manufacturers 2.1 Global Patent Medicine Sales Market Share by Manufacturers (2016-2021) 2.2 Global Patent Medicine Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Patent Medicine Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Patent Medicine Manufacturing Sites, Area Served, Product Type 2.5 Patent Medicine Market Competitive Situation and Trends 2.5.1 Patent Medicine Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Patent Medicine Players Market Share by Revenue 2.5.3 Global Patent Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Patent Medicine Retrospective Market Scenario by Region 3.1 Global Patent Medicine Retrospective Market Scenario in Revenue by Region: 2016-2021 3.2 Global Patent Medicine Retrospective Market Scenario in Sales by Region: 2016-2021 3.3 North America Patent Medicine Market Facts & Figures by Country 3.3.1 North America Patent Medicine Sales by Country 3.3.2 North America Patent Medicine Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Patent Medicine Market Facts & Figures by Country 3.4.1 Europe Patent Medicine Sales by Country 3.4.2 Europe Patent Medicine Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Patent Medicine Market Facts & Figures by Region 3.5.1 Asia Pacific Patent Medicine Sales by Region 3.5.2 Asia Pacific Patent Medicine Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Patent Medicine Market Facts & Figures by Country 3.6.1 Latin America Patent Medicine Sales by Country 3.6.2 Latin America Patent Medicine Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Patent Medicine Market Facts & Figures by Country 3.7.1 Middle East and Africa Patent Medicine Sales by Country 3.7.2 Middle East and Africa Patent Medicine Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Patent Medicine Historic Market Analysis by Type 4.1 Global Patent Medicine Sales Market Share by Type (2016-2021) 4.2 Global Patent Medicine Revenue Market Share by Type (2016-2021) 4.3 Global Patent Medicine Price by Type (2016-2021) 5 Global Patent Medicine Historic Market Analysis by Application 5.1 Global Patent Medicine Sales Market Share by Application (2016-2021) 5.2 Global Patent Medicine Revenue Market Share by Application (2016-2021) 5.3 Global Patent Medicine Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Pfizer Inc. 6.1.1 Pfizer Inc. Corporation Information 6.1.2 Pfizer Inc. Description and Business Overview 6.1.3 Pfizer Inc. Patent Medicine Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Pfizer Inc. Product Portfolio 6.1.5 Pfizer Inc. Recent Developments/Updates 6.2 Otsuka Pharmaceutical 6.2.1 Otsuka Pharmaceutical Corporation Information 6.2.2 Otsuka Pharmaceutical Description and Business Overview 6.2.3 Otsuka Pharmaceutical Patent Medicine Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Otsuka Pharmaceutical Product Portfolio 6.2.5 Otsuka Pharmaceutical Recent Developments/Updates 6.3 Merck 6.3.1 Merck Corporation Information 6.3.2 Merck Description and Business Overview 6.3.3 Merck Patent Medicine Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Merck Product Portfolio 6.3.5 Merck Recent Developments/Updates 6.4 Novartis 6.4.1 Novartis Corporation Information 6.4.2 Novartis Description and Business Overview 6.4.3 Novartis Patent Medicine Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Novartis Product Portfolio 6.4.5 Novartis Recent Developments/Updates 6.5 Sanofi-Aventis 6.5.1 Sanofi-Aventis Corporation Information 6.5.2 Sanofi-Aventis Description and Business Overview 6.5.3 Sanofi-Aventis Patent Medicine Sales, Revenue and Gross Margin (2016-2021) 6.5.4 Sanofi-Aventis Product Portfolio 6.5.5 Sanofi-Aventis Recent Developments/Updates 6.6 Bristol-Myers Squibb Co. 6.6.1 Bristol-Myers Squibb Co. Corporation Information 6.6.2 Bristol-Myers Squibb Co. Description and Business Overview 6.6.3 Bristol-Myers Squibb Co. Patent Medicine Sales, Revenue and Gross Margin (2016-2021) 6.6.4 Bristol-Myers Squibb Co. Product Portfolio 6.6.5 Bristol-Myers Squibb Co. Recent Developments/Updates 6.7 GSK 6.6.1 GSK Corporation Information 6.6.2 GSK Description and Business Overview 6.6.3 GSK Patent Medicine Sales, Revenue and Gross Margin (2016-2021) 6.4.4 GSK Product Portfolio 6.7.5 GSK Recent Developments/Updates 7 Patent Medicine Manufacturing Cost Analysis 7.1 Patent Medicine Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Patent Medicine 7.4 Patent Medicine Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Patent Medicine Distributors List 8.3 Patent Medicine Customers 9 Patent Medicine Market Dynamics 9.1 Patent Medicine Industry Trends 9.2 Patent Medicine Growth Drivers 9.3 Patent Medicine Market Challenges 9.4 Patent Medicine Market Restraints 10 Global Market Forecast 10.1 Patent Medicine Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Patent Medicine by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Patent Medicine by Type (2022-2027) 10.2 Patent Medicine Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Patent Medicine by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Patent Medicine by Application (2022-2027) 10.3 Patent Medicine Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Patent Medicine by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Patent Medicine by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Patent Medicine Sales (K Doses) Growth Rate Comparison by Type (2021-2027) Table 2. Global Patent Medicine Sales (K Doses) Comparison by Application (2021-2027) Table 3. Global Patent Medicine Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Patent Medicine Covered in This Study Table 5. Global Patent Medicine Sales (K Doses) of Key Manufacturers (2016-2021) Table 6. Global Patent Medicine Sales Share by Manufacturers (2016-2021) Table 7. Global Patent Medicine Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Patent Medicine Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Patent Medicine Average Price (USD/Dose) of Key Manufacturers (2016-2021) Table 10. Manufacturers Patent Medicine Manufacturing Sites and Area Served Table 11. Manufacturers Patent Medicine Product Type Table 12. Global Patent Medicine Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Patent Medicine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Patent Medicine as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Patent Medicine Sales by Region (2016-2021) & (K Doses) Table 16. Global Patent Medicine Sales Market Share by Region (2016-2021) Table 17. Global Patent Medicine Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Patent Medicine Sales by Country (2016-2021) & (K Doses) Table 19. North America Patent Medicine Sales Market Share by Country (2016-2021) Table 20. North America Patent Medicine Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Patent Medicine Revenue Market Share by Country (2016-2021) Table 22. Europe Patent Medicine Sales by Country (2016-2021) & (K Doses) Table 23. Europe Patent Medicine Sales Market Share by Country (2016-2021) Table 24. Europe Patent Medicine Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Patent Medicine Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Patent Medicine Sales by Region (2016-2021) & (K Doses) Table 27. Asia Pacific Patent Medicine Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Patent Medicine Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Patent Medicine Revenue Market Share by Region (2016-2021) Table 30. Latin America Patent Medicine Sales by Country (2016-2021) & (K Doses) Table 31. Latin America Patent Medicine Sales Market Share by Country (2016-2021) Table 32. Latin America Patent Medicine Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Patent Medicine Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Patent Medicine Sales by Country (2016-2021) & (K Doses) Table 35. Middle East and Africa Patent Medicine Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Patent Medicine Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Patent Medicine Revenue Market Share by Country (2016-2021) Table 38. Global Patent Medicine Sales (K Doses) by Type (2016-2021) Table 39. Global Patent Medicine Sales Market Share by Type (2016-2021) Table 40. Global Patent Medicine Revenue (Million US$) by Type (2016-2021) Table 41. Global Patent Medicine Revenue Share by Type (2016-2021) Table 42. Global Patent Medicine Price (USD/Dose) by Type (2016-2021) Table 43. Global Patent Medicine Sales (K Doses) by Application (2016-2021) Table 44. Global Patent Medicine Sales Market Share by Application (2016-2021) Table 45. Global Patent Medicine Revenue (Million US$) by Application (2016-2021) Table 46. Global Patent Medicine Revenue Share by Application (2016-2021) Table 47. Global Patent Medicine Price (USD/Dose) by Application (2016-2021) Table 48. Pfizer Inc. Corporation Information Table 49. Pfizer Inc. Description and Business Overview Table 50. Pfizer Inc. Patent Medicine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021) Table 51. Pfizer Inc. Patent Medicine Product Table 52. Pfizer Inc. Recent Developments/Updates Table 53. Otsuka Pharmaceutical Corporation Information Table 54. Otsuka Pharmaceutical Description and Business Overview Table 55. Otsuka Pharmaceutical Patent Medicine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021) Table 56. Otsuka Pharmaceutical Patent Medicine Product Table 57. Otsuka Pharmaceutical Recent Developments/Updates Table 58. Merck Corporation Information Table 59. Merck Description and Business Overview Table 60. Merck Patent Medicine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021) Table 61. Merck Patent Medicine Product Table 62. Merck Recent Developments/Updates Table 63. Novartis Corporation Information Table 64. Novartis Description and Business Overview Table 65. Novartis Patent Medicine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021) Table 66. Novartis Patent Medicine Product Table 67. Novartis Recent Developments/Updates Table 68. Sanofi-Aventis Corporation Information Table 69. Sanofi-Aventis Description and Business Overview Table 70. Sanofi-Aventis Patent Medicine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021) Table 71. Sanofi-Aventis Patent Medicine Product Table 72. Sanofi-Aventis Recent Developments/Updates Table 73. Bristol-Myers Squibb Co. Corporation Information Table 74. Bristol-Myers Squibb Co. Description and Business Overview Table 75. Bristol-Myers Squibb Co. Patent Medicine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021) Table 76. Bristol-Myers Squibb Co. Patent Medicine Product Table 77. Bristol-Myers Squibb Co. Recent Developments/Updates Table 78. GSK Corporation Information Table 79. GSK Description and Business Overview Table 80. GSK Patent Medicine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021) Table 81. GSK Patent Medicine Product Table 82. GSK Recent Developments/Updates Table 83. Production Base and Market Concentration Rate of Raw Material Table 84. Key Suppliers of Raw Materials Table 85. Patent Medicine Distributors List Table 86. Patent Medicine Customers List Table 87. Patent Medicine Market Trends Table 88. Patent Medicine Growth Drivers Table 89. Patent Medicine Market Restraints Table 90. Global Patent Medicine Sales Forecast by Type (2022-2027) & (K Doses) Table 91. Global Patent Medicine Sales Market Share Forecast by Type (2022-2027) Table 92. Global Patent Medicine Revenue Forecast by Type (2022-2027) & (US$ Million) Table 93. Global Patent Medicine Revenue Market Share Forecast by Type (2022-2027) Table 94. Global Patent Medicine Sales Forecast by Application (2022-2027) & (K Doses) Table 95. Global Patent Medicine Sales Market Share Forecast by Application (2022-2027) Table 96. Global Patent Medicine Revenue Forecast by Application (2022-2027) & (US$ Million) Table 97. Global Patent Medicine Revenue Market Share Forecast by Application (2022-2027) Table 98. Global Patent Medicine Sales Forecast by Region (2022-2027) & (K Doses) Table 99. Global Patent Medicine Sales Market Share Forecast by Region (2022-2027) Table 100. Global Patent Medicine Revenue Forecast by Region (2022-2027) & (US$ Million) Table 101. Global Patent Medicine Revenue Market Share Forecast by Region (2022-2027) Table 102. Research Programs/Design for This Report Table 103. Key Data Information from Secondary Sources Table 104. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Patent Medicine Figure 2. Global Patent Medicine Market Share by Type in 2020 & 2027 Figure 3. Product Patents Product Picture Figure 4. Process Patents Product Picture Figure 5. Global Patent Medicine Market Share by Application in 2020 & 2027 Figure 6. Adult Figure 7. Children Figure 8. Global Patent Medicine Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 9. Global Patent Medicine Market Size 2016-2027 (US$ Million) Figure 10. Global Patent Medicine Sales 2016-2027 (K Doses) Figure 11. Global Patent Medicine Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 12. Patent Medicine Sales Share by Manufacturers in 2020 Figure 13. Global Patent Medicine Revenue Share by Manufacturers in 2020 Figure 14. The Global 5 and 10 Largest Patent Medicine Players: Market Share by Revenue in 2020 Figure 15. Patent Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 16. Global Patent Medicine Sales Market Share by Region (2016-2021) Figure 17. Global Patent Medicine Sales Market Share by Region in 2020 Figure 18. Global Patent Medicine Revenue Market Share by Region (2016-2021) Figure 19. Global Patent Medicine Revenue Market Share by Region in 2020 Figure 20. U.S. Patent Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 21. Canada Patent Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 22. Germany Patent Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 23. France Patent Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 24. U.K. Patent Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. Italy Patent Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. Russia Patent Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. China Patent Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. Japan Patent Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. South Korea Patent Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. India Patent Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. Australia Patent Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. Taiwan Patent Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. Indonesia Patent Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Thailand Patent Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Malaysia Patent Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Philippines Patent Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Vietnam Patent Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Mexico Patent Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Brazil Patent Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Argentina Patent Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Turkey Patent Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Saudi Arabia Patent Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. U.A.E Patent Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Sales Market Share of Patent Medicine by Type (2016-2021) Figure 45. Sales Market Share of Patent Medicine by Application (2016-2021) Figure 46. Sales Market Share of Patent Medicine by Application in 2020 Figure 47. Revenue Share of Patent Medicine by Application (2016-2021) Figure 48. Revenue Share of Patent Medicine by Application in 2020 Figure 49. Manufacturing Cost Structure of Patent Medicine Figure 50. Manufacturing Process Analysis of Patent Medicine Figure 51. Patent Medicine Industrial Chain Analysis Figure 52. Channels of Distribution Figure 53. Distributors Profiles Figure 54. Bottom-up and Top-down Approaches for This Report Figure 55. Data Triangulation Figure 56. Key Executives Interviewed

Pfizer Inc. Otsuka Pharmaceutical Merck Novartis Sanofi-Aventis Bristol-Myers Squibb Co. GSK